Commit To Purchase Fate Therapeutics At $5, Earn 20% Annualized Using Options
January 10, 2018 at 11:55 AM EST
Investors eyeing a purchase of Fate Therapeutics Inc (FATE) shares, but cautious about paying the going market price of $6.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $5 strike, which has a bid at the time of this writing of 60 cents..
